This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
這位分析師看好耐克；以下是週五的五個最佳升級
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
頂尖華爾街分析師改變對這些頂級股票的前景看法。如需全面了解所有分析師評級的變化，包括升級、降級和啓動，請參閱我們的分析師評級頁面。
- Oppenheimer analyst Brian Nagel upgraded the rating for NIKE, Inc. (NYSE:NKE) from Perform to Outperform, while raising the price target from $110 to $120. Nike shares gained 0.8% to close at $95.57 on Thursday. See how other analysts view this stock.
- Morgan Stanley analyst Carlos De Alba upgraded Alcoa Corporation (NYSE:AA) from Equal-Weight to Overweight and boosted the price target from $36.5 to $50. Alcoa shares gained 4% to close at $38.98 on Thursday. See how other analysts view this stock.
- RBC Capital analyst Shagun Singh upgraded the rating for Outset Medical, Inc. (NASDAQ:OM) from Sector Perform to Outperform, while increasing the price target from $5 to $6. Outset Medical shares fell 1.5% to settle at $3.5850 on Thursday. See how other analysts view this stock.
- Morgan Stanley analyst Carlos De Alba upgraded Freeport-McMoRan Inc. (NYSE:FCX) from Equal-Weight to Overweight and boosted the price target from $49.5 to $62. Freeport-McMoRan shares gained 3.5% to close at $49.36 on Thursday. See how other analysts view this stock.
- DA Davidson analyst Linda Bolton Weiser upgraded the rating for Prestige Consumer Healthcare Inc. (NYSE:PBH) from Neutral to Buy, while raising the price target from $65 to $93. Prestige Consumer shares settled at $65.28 on Thursday. See how other analysts view this stock.
- Oppenheimer分析師Brian Nagel將NIKE Inc.（NYSE：NKE）的評級從執行升級爲跑贏大市，並將價格目標從110美元上調至120美元。週四，耐克股票上漲0.8％，收於95.57美元。請看其它分析師如何看待這隻股票。
- Morgan Stanley分析師Carlos De Alba將美國鋁業公司（NYSE：AA）的評級從平權升級爲超重，並將價格目標從36.5美元上調至50美元。週四，美國鋁業公司股票上漲4％，收於38.98美元。請看其它分析師如何看待這隻股票。
- RBC Capital分析師Shagun Singh將Outset Medical，Inc.（NASDAQ：OM）的評級從業績持平升級爲跑贏大市，並將價格目標從5美元上調至6美元。週四，Outset Medical股票下跌1.5％，收於3.5850美元。請看其它分析師如何看待這隻股票。
- 摩根士丹利的分析師Carlos De Alba將Freeport-McMoRan Inc.（NYSE：FCX）的評級從平權升級爲超重，並將價格目標從49.5美元上調至62美元。週四，Freeport-McMoRan股票上漲3.5％，收於49.36美元。請看其它分析師如何看待這隻股票。
- DA Davidson分析師Linda Bolton Weiser將Prestige Consumer Healthcare Inc.（NYSE：PBH）的評級從中立調升爲買入，同時將價格目標從65美元上調至93美元。 Prestige Consumer股票週四收於65.28美元。請看其它分析師如何看待這隻股票。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。